Retroviral packaging cell lines were constructed by using the gag-pol gene of spleen necrosis virus, the gag-pol gene of Moloney murine leukaemia virus and the env gene of bovine leukaemia virus. The plasmids containing the gag-pol genes and the plasmid containing the env gene were cotransfected into NIH/3T3 and D17 cells. The cells containing the helper virus constructs were tested for their ability to package replication-defective routine leukaemia and avian reticuloendotheliosis retrovirus vectors. The titre of vector virus produced by each of the retroviral packaging cell lines was about 102 colony-forming units per ml of medium. Tests for events that might result in intact replication-competent retroviruses showed no evidence for the generation of such viruses. The vector viruses were able to infect dog and rat cells. Bovine cells were infected only after their cocultivation with the retroviral packaging cell lines producing murine leukaemia virus vectors, perhaps as a result of a low concentration of receptors.
INTRODUCTION
Recombinant DNA techniques and the technology of embryo manipulation and gene transfer have provided means to introduce specific genes into animals in such a way that they are expressed and are transmitted through the germ line. Infection of mouse embryos with DNA from viruses such as simian virus 40 (SV40) or Moloney murine leukaemia virus (MLV) constitutes one method of genetically manipulating mouse embryos. These experiments resulted in the generation of the first transgenic mouse strains (Jaenisch, 1976 (Jaenisch, , 1977 Harbers et al., 1981 a, b) . A more commonly used technique for generating transgenic animals is the direct microinjection of recombinant D NA into a pronucleus of the fertilized egg (Brinster et al., 1981 ; Cline et al., 1980; Gordon et al., 1980) . The principal advantage of this method is that it generates transgenic lines that express most genes in a predictable manner. The disadvantage of this method is that it cannot be used to introduce genes into cells at later developmental stages. Other experiments have used retroviral vectors (Eglitis et al., 1985; Gruber et al., 1985; Williams et al., 1984 Williams et al., , 1986 . Recently developed techniques involving the introduction of DNA into embryonic stem ceils by the use of retroviral vectors have the advantage of the technical ease with which the virus can be introduced into embryos at different developmental stages (Robertson et al., 1986; Kuehn et al., 1987) . The main disadvantages of this method are the size limitation on the introduced DNA, the unresolved problem of reproducible expression of the introduced gene in the animal, and the possibility that replication-competent virus could form and proliferate. This proliferation could lead to multiple integrations into the genome, which might result in harmful consequences (Neel et al., 1981 ; Varmus et al., 1981) . Retroviral packaging cell lines containing different helper virus DNAs have been constructed: spleen necrosis virus (SNV)-based packaging cell lines (Watanabe & Temin, 1983) , MLV-based ecotropic packaging cell lines (Mann et al., 1983) and MLV-based amphotropic 1" Present address: Cancer Research Institute of Slovak Academy of Sciences, Bratislava, Czechoslovakia. 0000-8837 © 1989 SGM packaging cell lines (Cone & Mulligan, 1984; Miller et al., 1985) . These packaging cell lines contain retroviral sequences coding for the retroviral trans factors, the gag, pol and env proteins.
Three main types of helper cell lines have been described. First, there are packaging cell lines where the signal sequences for the packaging of viral RNA (E sequences) have been deleted (Mann et al., 1983; Cone & Mulligan, 1984; Miller et al., 1985) , in which recombination events can produce intact retrovirus; secondly, packaging cell lines have been constructed in which additional mutations have been made, including deletions in the Y long terminal repeat (LTR) of the helper virus component and additional deletion of portions of the 5' LTR (Miller & Buttimore, 1986) ; thirdly, other packaging cell lines contain the gag and pol genes on one plasmid and the env gene on another (Watanabe & Temin, 1983) , and where in addition both plasmids have deletions of the packaging sequences and either the 5' or the Y LTRs (Bosselman et al., 1987; Markowitz et al., 1988) .
We decided to construct packaging cell lines expressing the bovine leukaemia virus (BLV) env gene so that bovine cells could be more efficiently infected. We used the gag-po! genes from SNV and from MLV so we could use pre-existing SNV and MLV vectors. We placed thegag-pol genes and the env genes on separate plasmids; these genes and plasmids had no sequence identity with the vectors. This procedure prevented any homologous genetic interactions between the vector and helper cell sequences.
METHODS

Preparation ofplasmid constructions.
To create BLV packaging cell lines, the gag-pal genes of MLV from the plasmid pMOV-3 (Harbers et al., 1981 b) , the gag-pal gene of SNV from pSW279 (Watanabe & Temin, 1983 ) and the env gene of BLV from pBLV (Sagata et al., 1985) were introduced separately into the expression plasmid pJDCM-SV (Fig. 1) . pJBgpM was constructed by inserting the 5.4 kbp AatlI to Sinai fragment from pMOV-3 containing the gag-pal gene of MLV (bp 363 to 5748) into the filled-in Sail site of pJDCM-SV.
pJBgpS was made in a similar fashion. The 6 kbp KpnI-BglII fragment from pSW279 containing the gag-pal gene of SNV (bp 676 to 6626) was inserted into the filled-in Sail site of pJDCM-SV.
pJBeB was constructed in a similar fashion. The 2-1 kbp XhoI-PvulI fragment from pBLV containing the BLV env gene (hp 4533 to 6693) was inserted into the filled-in Sail site of pJDCM-SV.
Plasmid pSV2~3.6 is a ouabain resistance (oua)-containing vector with the SV40 early promoter 5' to the oua gene and the SV40 polyadenylation signal 3' to the oua gene (Kent et al., 1987) .
Transfection of DNA and cell analysis. NIH/3T3 (mouse) and D17 (dog) cells were transfected with plasmids using the DMSO/polybrene procedure (Kawai & Nishizawa, 1984) . For each experiment, 3 x 105 or 4 x 105 cells were plated on 60 mm Petri dishes. For cotransfection experiments, the mass ratio of the non-selectable plasmid DNA to the selectable plasmid DNA was 2:1. NIH/3T3 cells were propagated in Temin's modified Eagle's medium (Temin, 1977) supplemented with 4% calf serum. D17 cells were propagated in the same medium supplemented with 7% foetal bovine serum. Selective medium was added 24 h after transfection. The concentrations of G418 and ouabain in the medium were 400 Ixg/ml and 10 -7 M, respectively.
The NIH/3T3 cellline with the gag-pal genes of SNV and the env gene of BLV (3T3gpSeB) was prepared by two cotransfections. The non-selectable plasmid pJBeB and the selectable plasmid pSV2neo were cotransfected into NIH/3T3 cells, and neomycin-resistant (Neo9 cells were selected. The non-selectable plasmid pJBgpS and the selectable plasmid pSV2~3.6, which codes for ouabain (Oua) resistance, were then cotransfected into these Neo r NIH/3T3 cells, and Oua r cells were selected.
The NIH/3T3 cell line with the gag-pal genes of MLV and the env gene of BLV (3T3gpMeB) was also prepared by two cotransfections. The non-selectable plasmid pJBeB and the selectable plasmid pSV2neo were cotransfected into NIH/3T3 cells, and Neo r cells were selected. The non-selectable plasmid pJBgpM and the selectable plasmid pSV2c¢3.6 were then cotransfected into these Neo r NIH/3T3 cells, and Oua r cells were selected.
The DI7 cell line with the gag-pal genes of SNV and the env gene of BLV (D17gpSeB) was prepared by a simultaneous triple transfection of two non-selectable plasmids, pJBpgS and pJBeB, and one selectable plasmid, pSV2neo, into D17 cells. Neo r cells were selected. These cells were then subcloned, and D17gpSeBcl. 1 was obtained.
The D 17 cell line with the gag-pal genes of MLV and the env gene of BLV (D 17gpMeB) was prepared by two cotransfections. The non-selectable plasmid pJBeB and the selectable plasmid pSV2neo were cotransfected into D17 cells, and Neo T cells were selected. The non-selectable plasmid pJBeB and the selectable plasmid pSV2~3.6 were then cotransfected into these Neo r D17 cells, and Oua r cells were selected. These cells were then subcloned, and D17gpMeBcl. 1 was obtained.
Incorporation of the SNV gag-pal, the BLV env and the M LV gag-pal genes into the genomes of these cell lines was confirmed by Southern blotting techniques (data not shown; Southern, 1975 
RESULTS
Ability of cell lines to package retroviral vectors
To test the packaging ability of these new helper cell lines (Table 1 describes the helper cell lines used), they were transfected with plasmids containing retroviral vectors (Fig. 2 ). The transfected cells were then selected with hygromycin B (80 p,g/ml), and supernatant medium from each transfected retroviral packaging cell line was used to infect D17 cells (Dornburg & Temin, 1988; Dougherty & Temin, 1987) . The titre of vector virus produced by each of the retroviral packaging cell lines was 102 to 103 c.f.u./ml on D17 cells (Table 2) .
To determine whether or not the virus from these packaging cell lines used the BLV env proteins, D17gpMeB and D17gpSeB packaging cell lines were infected with supernatant medium from several of the vector virus-producing retroviral packaging cell lines, and the infected cells were selected with hygromycin B. The titre of the vector viruses on the BLV envexpressing cells was lower than on D17 cells (Table 3 ). This decrease in titre is probably a consequence of interference by the BLV env proteins on the helper cell lines. These results indicate that the product of BLV env is in the virus particles from these packaging cell lines.
Analysis for possible recombinant infectious retrovirus
To test for the presence of replication-competent retrovirus, supernatant media from two vector virus-infected retroviral packaging cell lines (3T3gpMeB cells transfected with AFVXM-SV-Hy and D17gpSeB cells transfected with pJD214Hy) were used to infect D17 cells. The infected cells were selected with hygromycin B and passaged three times. Supernatant medium from a confluent layer of resistant cells was then used to infect fresh NIH/bT3 and D17 cells (secondary infection). These cells were again selected with hygromycin B. No surviving resistant cells resulted. The supernatant media from vector virus-infected D17 cells also contained no reverse transcriptase activity (Table 2 ). These results indicate that there is no recovery of replication-competent virus from the NIH/bT3 or D17 helper cell lines producing the vectors. 
Host range o f vector viruses produced by packaging cell lines
To determine the ability of the vector viruses produced by these packaging cell lines to infect different cell lines, rat cells (Rat-l) were infected with the supernatant medium from two retroviral packaging cell lines (3T3gpMeB cells transfected with A F V X M -S V -H y and D 17gpSeB cells transfected with pJD214Hy), and the bovine cells listed in Table 4 were infected with the supernatant medium from all of the BLV retroviral packaging cell lines. Only the rat cells were infected (data not shown). The titres of vector virus were about 10 z c.f.u./ml.
However, when bovine cells were cocultivated with mitomycin C-treated packaging cell lines, the A F V X M -S V -H y vector was able to infect and be expressed in the bovine cells (Table 4) . There were about 100 infected colonies recovered per culture.
DISCUSSION
We prepared retroviral packaging cell lines containing the gag-pol genes from SNV and from MLV and the env gene from BLV. We showed that these packaging cell lines produced vector viruses that infected dog and rat cell lines. Thus, retrovirus virions can be made with envelope proteins from one subfamily of retroviruses and internal proteins from another subfamily. This approach has been extended to other retroviruses (Dougherty et al., 1989) . t Virus titres were determined by infection of D17 cells with 0-2 ml of supernatant medium harvested from confluent helper cells. Each experiment was done twice, and two dishes of D17 cells were infected each time. Colonies were counted 3 weeks after infection.
~: Supernatant media from pools of vector virus-infected D 17 cells were analysed for the vector virus by infection of D17 and NIH/3T3 cells with 0-5 ml of supernatant medium harvested from confluent cells that had been inoculated with vector virus and passaged three times in 10 days before media were harvested.
§ Supernatant medium from pools of vector virus-infected D 17 cells were assayed for reverse transcriptase (RT) activity.
II ND, Not done. ¶-, Negative. * Virus titres (c.f.u./ml) were determined by infection of D17 and BLV packaging cell lines with 0.2 ml of supernatant medium harvested from confluent helper cells. Each experiment was done twice, and two dishes of each kind were infected each time. were done by incubation of the retroviral packaging cell lines with mitomycin C (10 ~tg/ml) for 2 h. These cells were then mixed with bovine cells in the ratio 1 : 1 and cocultivated for 24 h. After cocultivation, the ceils were selected with hygromycin B, and colonies were counted 3 weeks after cocultivation. t BEC, bovine embryonic chorion cells; BESC, bovine embryonic spleen cells; BTC, bovine testicular cells; MDBK, bovine kidney cells.
:~ Number of colonies per dish.
We found no evidence for genetic events that resulted in the production of replicationcompetent virus. Thus, preparation of other retrovirus helper cell lines with no sequence homology to the vectors may provide a system for animal and human infection with less chance of formation of replication-competent retroviruses.
The low titre of vector virus from the new helper cells (102 to 103 c.f.u./ml) could reflect at least two factors. First, the BLV env gene in the packaging cell lines could have been expressed at low levels, a possible consequence of the absence of any of the BLV trans-activating factors which are important for BLV env gene expression (Itohara et al., 1988) . Second, there may be only a limited ability to package retroviral gene products from different subfamilies into one virion. Radioimmunoprecipitation of labelled helper cells with anti-BLV env sera showed low production of env protein (J. Ban, C. Altaner & V. Altanerova, unpublished). Although we demonstrated the ability of these BLV packaging cell lines to produce vector virus that could infect rat cells, our attempts to infect bovine cell lines with virions produced by these BLV packaging cell lines were not successful. This failure could be the result of a block to the function of the heterologous SNV and MLV gag-pol proteins and LTRs in bovine cells or of the low virus titre. However, we were successful in infecting bovine cell lines after cocultivation with these BLV retroviral packaging cell lines. This result indicates that the AFVXM-Sy-Hy vector was able to be reverse-transcribed, integrated and expressed in bovine ceils. Thus, we suggest that the failure of infection of bovine cells in culture by these vectors from the BLV env helper cells was a result of the low titre and/or a low receptor level on the bovine cells.
